SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 168 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 3.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $157,000 | -42.1% | 123,918 | -0.4% | 0.00% | -33.3% |
| Q3 2021 | $271,000 | -41.7% | 124,428 | +0.4% | 0.00% | -40.0% |
| Q2 2021 | $465,000 | +26.7% | 123,954 | +10.1% | 0.01% | 0.0% |
| Q1 2021 | $367,000 | -4.7% | 112,535 | -0.4% | 0.01% | 0.0% |
| Q4 2020 | $385,000 | -16.5% | 113,039 | -0.0% | 0.01% | -44.4% |
| Q3 2020 | $461,000 | +136.4% | 113,086 | +95.7% | 0.01% | +125.0% |
| Q2 2020 | $195,000 | +47.7% | 57,787 | +1.7% | 0.00% | +33.3% |
| Q1 2020 | $132,000 | -5.0% | 56,840 | +48.4% | 0.00% | +50.0% |
| Q4 2019 | $139,000 | -56.3% | 38,300 | +0.1% | 0.00% | -66.7% |
| Q3 2019 | $318,000 | +1.3% | 38,279 | +5.1% | 0.01% | +20.0% |
| Q2 2019 | $314,000 | -18.9% | 36,429 | +0.6% | 0.01% | -28.6% |
| Q1 2019 | $387,000 | +26.9% | 36,208 | +4.0% | 0.01% | +16.7% |
| Q4 2018 | $305,000 | -23.0% | 34,827 | +47.6% | 0.01% | 0.0% |
| Q3 2018 | $396,000 | -4.6% | 23,599 | +19.1% | 0.01% | 0.0% |
| Q2 2018 | $415,000 | – | 19,810 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,177,115 | $1,495,000 | 1.27% |
| ARMISTICE CAPITAL, LLC | 9,665,756 | $12,276,000 | 0.20% |
| CM Management, LLC | 150,000 | $191,000 | 0.14% |
| FSB PREMIER WEALTH MANAGEMENT, INC. | 200,000 | $254,000 | 0.11% |
| Manteio Capital LLC | 57,586 | $73,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 410,691 | $522,000 | 0.07% |
| SYNTAX ADVISORS, LLC | 29,181 | $37,000 | 0.03% |
| CAXTON ASSOCIATES LP | 164,096 | $208,000 | 0.02% |
| Alpine Global Management, LLC | 97,650 | $124,000 | 0.02% |
| Sonora Investment Management Group, LLC | 82,000 | $104,000 | 0.01% |